Sartorius 2025r. ALT ITEM 26582 R300S Digital Scale Sartorius offers solutions for the biopharmaceutical industry and laboratories, from drug discovery and development to production platforms for biomanufacturing Sartorius manages its bioprocess business as a legally independent subgroup whose parent corporation is Sartorius Stedim Biotech S.A., which is listed on Euronext Paris
Sartorius Aktie Leichter Kursrückgang trotz stabiler Position () aktiencheck.de from www.aktiencheck.de
Minisart ® RC is optimized for aqueous liquids as well as solvents and is stable against DMSO, other amides, ketones, esters and ethers As of February 09, 2024, Sartorius AG held around 71.5% of the shares of Sartorius Stedim Biotech S.A
Sartorius Aktie Leichter Kursrückgang trotz stabiler Position () aktiencheck.de
Visit SLAS Europe 2025 Conference & Exhibition and discover the latest products in Sartorius BioA portfolio! Sartorius will showcase the latest innovations in BioA technology at booth 1001 Sartorius | Biopharma, Laboratory, Applied & Life Sciences Visit SLAS Europe 2025 Conference & Exhibition and discover the latest products in Sartorius BioA portfolio! Sartorius will showcase the latest innovations in BioA technology at booth 1001
Sartorius Scale Core Facilities. Sartorius | Biopharma, Laboratory, Applied & Life Sciences The SLAS Europe 2025 Conference and Exhibition will bring together the European life sciences and laboratory technology community in Hamburg, from May 20-22, 2025.
Sartorius Picus™ 2 Electronic 8Channel Pipette Volume (Metric) 10 to 300 μL Fisher Scientific. It operates in two segments: bioprocess solutions and lab products and services In 2025, Sartorius will continue its organic debt reduction course with a focus on working capital and managing investments